Security key
46489V302
Perspective Therapeutics, Inc. - Common Stock, $0.001 par value (CATX)
CUSIP: 46489V302
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 35,179,307
- Total 13F value
- $96,743,275
- Share change
- -7,064,114
- SEC-reported price per share
- $2.75
- Number of holders
- 114
- Value change
- -$20,013,129
- Number of buys
- 53
- Number of sells
- 45
- Shares outstanding
- 114,405,130
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
114
Top holders
10
CATX full security history
Ownership snapshot
Full 13F holder table
Perspective Therapeutics, Inc. SEC filings
Perspective Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CATX - Perspective Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lantheus Holdings, Inc.
Disclosed value leader
Lantheus Holdings, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 10%
13D/G row: Lantheus Holdings, Inc.
Showing 1-6 of 15 holder rows.
Quick read
Lantheus Holdings, Inc. leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lantheus Holdings, Inc.'s linked filing trail.
Comparable ownership
Top 5
Lantheus Holdings, Inc.
10%
FMR LLC
0.4%
Janus Henderson Group Ltd.
0.02%
BlackRock, Inc.
3.8%
VANGUARD GROUP INC
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lantheus Holdings, Inc. |
13D/G
|
10%
|
$35,465,590
11,440,513 shares
|
$0 | 15 May 2024 |
| FMR LLC |
13F
13D/G
Company
|
0.4%
from 13D/G
|
$34,337,267
10,010,865 shares
|
— | 30 Sep 2025 |
| Janus Henderson Group Ltd. |
13D/G
JANUS HENDERSON GROUP PLC
|
0.02%
|
$43,349
17,839 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
3.8%
|
$14,977,359
4,366,577 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3%
|
$11,791,877
3,437,865 shares
|
— | 30 Sep 2025 |
| Avidity Partners Management LP |
13F
Company
|
2.6%
|
$10,269,533
2,994,033 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
114
Shares
35,179,307
Rows available
114
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
103
Q4 2025 holders
114
Holder diff
11
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|